Encinitas, CA, United States of America

David Larocca

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 2000-2015

Loading Chart...
8 patents (USPTO):Explore Patents

Title: David Larocca: Pioneering Innovations in Cell Technology

Introduction

David Larocca is an accomplished inventor based in Encinitas, California, known for his contributions to the field of cellular technology. With a portfolio of eight patents, he has significantly advanced methods for targeting progenitor cell lines and gene delivery systems.

Latest Patents

Among David Larocca's latest patents are two notable inventions. The first patent focuses on "Methods and compositions for targeting progenitor cell lines," which provides innovative methods, compositions, and kits aimed at identifying and enriching progenitor cell lines derived from pluripotent stem cells. The second patent, "Receptor-mediated gene delivery using bacteriophage vectors," utilizes filamentous phage particles that display ligands on their surfaces to deliver therapeutic genes into cells. This method involves a fusion protein with a phage capsid protein that is either covalently conjugated to phage particles or complexed with modified phage particles.

Career Highlights

Throughout his career, David has worked with companies that have laid the groundwork for advancements in genetic engineering and cellular therapies. One prominent company he has been associated with is Selective Genetics, Inc., where he harnessed his expertise to make impactful innovations in the field.

Collaborations

David Larocca has collaborated with notable professionals such as Andrew J. Baird and Paul D. Kassner. These partnerships have contributed to his success in developing cutting-edge technologies and methodologies that push the boundaries of science.

Conclusion

David Larocca is a prominent inventor whose work has brought forth innovative solutions in the realm of progenitor cell lines and gene delivery systems. His patents demonstrate a commitment to advancing cellular technology and improving therapeutic approaches, making him a key figure in the landscape of genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…